Dispensability of Jak1 tyrosine kinase for interleukin-2-induced cell growth signaling in a human T cell line

被引:41
作者
Higuchi, M
Asao, H
Tanaka, N
Oda, K
Takeshita, T
Nakamura, M
VanSnick, J
Sugamura, K
机构
[1] TOHOKU UNIV,SCH MED,DEPT MICROBIOL,AOBA KU,SENDAI,MIYAGI 98077,JAPAN
[2] TOKYO MED & DENT UNIV,HUMAN GENE SCI CTR,TOKYO 113,JAPAN
[3] LUDWIG INST CANC RES,BRUSSELS BRANCH,BRUSSELS,BELGIUM
关键词
interleukin-2; receptor; Jak1; Jak3; Stat5;
D O I
10.1002/eji.1830260622
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The tyrosine kinases Jak1 and Jak3 are known to be associated with the beta and gamma chains of interleukin-2 receptor (IL-2R). They are activated by stimulation with IL-2, IL-4, IL-7, IL-9, or IL-15, receptors of which share the gamma chain of the IL-2R. We have obtained direct evidence of Jak1 association with the a chains of receptors for IL-4, IL-7 and IL-9 and with the beta chain of IL-2R, which is also common to the IL-15R. Furthermore, we have prepared mutant IL-2R beta chains with a mutation in the box 1 region, which is conserved among the IL-2R beta chain and the alpha chains of the other cytokine receptors sharing the IL-2R gamma chain. Using MOLT-4 transfectants with the mutant beta chains, we found that two conserved proline residues within the box 1 region are essentially involved in association with Jak1. The MOLT-4 transfectants with the mutant beta chains lacking Jak1 association showed IL-2 responsiveness, in terms of activation of Jak3 and Stat5 and induction of cell growth, indicating that Jak1 is dispensable for IL-2-mediated cell growth signaling and that Jak1 activation is not required for activation of Jak3 and Stat5 in the MOLT-4 transfectants.
引用
收藏
页码:1322 / 1327
页数:6
相关论文
共 36 条
  • [21] ACTIVATION OF JAK2 KINASE MEDIATED BY THE INTERLEUKIN-6 SIGNAL TRANSDUCER GP130
    NARAZAKI, M
    WITTHUHN, BA
    YOSHIDA, K
    SILVENNOINEN, O
    YASUKAWA, K
    IHLE, JN
    KISHIMOTO, T
    TAGA, T
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (06) : 2285 - 2289
  • [22] INTERLEUKIN-2 INDUCES TYROSINE PHOSPHORYLATION AND NUCLEAR TRANSLOCATION OF STAT3 IN HUMAN T-LYMPHOCYTES
    NIELSEN, M
    SVEJGAARD, A
    SKOV, S
    ODUM, N
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 1994, 24 (12) : 3082 - 3086
  • [23] MULTISTEP REGULATION OF ENHANCER ACTIVITY OF THE 21-BASE-PAIR ELEMENT OF HUMAN T-CELL LEUKEMIA-VIRUS TYPE-I
    NIKI, M
    OHTANI, K
    NAKAMURA, M
    SUGAMURA, K
    [J]. JOURNAL OF VIROLOGY, 1992, 66 (07) : 4348 - 4357
  • [24] JAK2 ASSOCIATES WITH THE BETA(C) CHAIN OF THE RECEPTOR FAR GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR, AND ITS ACTIVATION REQUIRES THE MEMBRANE-PROXIMAL REGION
    QUELLE, FW
    SATO, N
    WITTHUHN, BS
    INHORN, RC
    EDER, M
    MIYAJIMA, A
    GRIFFIN, JD
    IHLE, JN
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 1994, 14 (07) : 4335 - 4341
  • [25] REAULD JC, 1992, P NATL ACAD SCI USA, V89, P5690
  • [26] 13 HYBRIDOMAS SECRETING HAPTEN-SPECIFIC IMMUNOGLOBULIN-E FROM MICE WITH IGA OR IGB HEAVY-CHAIN HAPLOTYPE
    RUDOLPH, AK
    BURROWS, PD
    WABL, MR
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 1981, 11 (06) : 527 - 529
  • [27] INTERACTION OF IL-2R-BETA AND GAMMA(C) CHAINS WITH JAK1 AND JAK3 - IMPLICATIONS FOR XSCID AND XCID
    RUSSELL, SM
    JOHNSTON, JA
    NOGUCHI, M
    KAWAMURA, M
    BACON, CM
    FRIEDMANN, M
    BERG, M
    MCVICAR, DW
    WITTHUHN, BA
    SILVENNOINEN, O
    GOLDMAN, AS
    SCHMALSTIEG, FC
    IHLE, JN
    OSHEA, JJ
    LEONARD, WJ
    [J]. SCIENCE, 1994, 266 (5187) : 1042 - 1045
  • [28] THE COMMON GAMMA-CHAIN FOR MULTIPLE CYTOKINE RECEPTORS
    SUGAMURA, K
    ASAO, H
    KONDO, M
    TANAKA, N
    ISHII, N
    NAKAMURA, M
    TAKESHITA, T
    [J]. ADVANCES IN IMMUNOLOGY, VOL 59, 1995, 59 : 225 - 277
  • [29] Suzuki J, 1989, Int Immunol, V1, P373, DOI 10.1093/intimm/1.4.373
  • [30] MONOCLONAL-ANTIBODY DEFINING A MOLECULE POSSIBLY IDENTICAL TO THE P75 SUBUNIT OF INTERLEUKIN-2 RECEPTOR
    TAKESHITA, T
    GOTO, Y
    TADA, K
    NAGATA, K
    ASAO, H
    SUGAMURA, K
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1989, 169 (04) : 1323 - 1332